FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034813612> ?p ?o ?g. }

• W2034813612 endingPage "4999" @default.
• W2034813612 startingPage "4986" @default.
• W2034813612 abstract "The inappropriate activation of complement may contribute to various immune diseases. The alternative pathway (AP) predominates during complement activation regardless of the initiating pathways. Hence, the main AP regulator factor H (FH) holds great potential as an attractive therapeutic intervention. In addition, complement receptor of the immunoglobulin superfamily (CRIg) has been demonstrated to inhibit AP and, more notably, still specifically binds to C3b/iC3b. We thus developed novel CRIg-targeted complement inhibitors by connecting the functional domains of CRIg and FH, which we termed CRIg-FH and CRIg-L-FH. CRIg-L-FH, slightly more potent than CRIg-FH, considerably inhibited both AP- and also classical pathway (CP)-mediated hemolysis and successfully eliminated the deposition of C3b/iC3b. Kinetic analysis further revealed that the binding affinity constant (KD) of CRIg/FH was in the micromolar range, consistent with its long-lasting binding to complement-attacked cells. CRIg-L-FH efficiently protected aberrant erythrocytes of patients with paroxysmal nocturnal hemoglobinuria (PNH) from AP-and CP-mediated complement damage (IC50 was 22.43 and 64.69 nM, respectively). Moreover, CRIg-L-FH was found to inhibit complement activation induced by the anti-Thy1 antibody in a mesangiopro-liferative glomerulonephritis (MPGN) rat model. Hence, CRIg-L-FH protects glomerular mesangial cells (GMCs) from complement-mediated injury and proliferative lesions. These findings strongly suggest that CRIg/FH is a potential therapeutic drug candidate for a range of complement-mediated diseases.—Qiao, Q., Teng, X., Wang, N., Lu, R., Guo, L., Zhang, X., Du, Y., Wang, W., Chen, S., Wu, Q., He, G., Wang, Y., and Hu, W., A novel CRIg-targeted complement inhibitor protects cells from complement damage. FASEB J. 28, 4986–4999 (2014). www.fasebj.org" @default.
• W2034813612 created "2016-06-24" @default.
• W2034813612 creator A5004347562 @default.
• W2034813612 creator A5006651636 @default.
• W2034813612 creator A5012463050 @default.
• W2034813612 creator A5018073098 @default.
• W2034813612 creator A5022501218 @default.
• W2034813612 creator A5035093874 @default.
• W2034813612 creator A5046732096 @default.
• W2034813612 creator A5068462524 @default.
• W2034813612 creator A5069617479 @default.
• W2034813612 creator A5076141593 @default.
• W2034813612 creator A5082227068 @default.
• W2034813612 creator A5090242706 @default.
• W2034813612 creator A5090728786 @default.
• W2034813612 date "2014-08-11" @default.
• W2034813612 modified "2023-09-26" @default.
• W2034813612 title "A novel CRIg‐targeted complement inhibitor protects cells from complement damage" @default.
• W2034813612 cites W121889566 @default.
• W2034813612 cites W1492385697 @default.
• W2034813612 cites W1499382446 @default.
• W2034813612 cites W1760063727 @default.
• W2034813612 cites W1826628219 @default.
• W2034813612 cites W1914909226 @default.
• W2034813612 cites W1970232820 @default.
• W2034813612 cites W1970718615 @default.
• W2034813612 cites W1971594322 @default.
• W2034813612 cites W1986341898 @default.
• W2034813612 cites W1990960985 @default.
• W2034813612 cites W1997797471 @default.
• W2034813612 cites W2004265876 @default.
• W2034813612 cites W2007685742 @default.
• W2034813612 cites W2014336891 @default.
• W2034813612 cites W2016339826 @default.
• W2034813612 cites W2019872371 @default.
• W2034813612 cites W2025576158 @default.
• W2034813612 cites W2040193568 @default.
• W2034813612 cites W2042222205 @default.
• W2034813612 cites W2054323447 @default.
• W2034813612 cites W2054891189 @default.
• W2034813612 cites W2055627054 @default.
• W2034813612 cites W2061501964 @default.
• W2034813612 cites W2070650369 @default.
• W2034813612 cites W2074202650 @default.
• W2034813612 cites W2078520528 @default.
• W2034813612 cites W2085037775 @default.
• W2034813612 cites W2093238184 @default.
• W2034813612 cites W2097972374 @default.
• W2034813612 cites W2113206498 @default.
• W2034813612 cites W2113784410 @default.
• W2034813612 cites W2125750727 @default.
• W2034813612 cites W2126092981 @default.
• W2034813612 cites W2126578468 @default.
• W2034813612 cites W2130696459 @default.
• W2034813612 cites W2134914390 @default.
• W2034813612 cites W2134940901 @default.
• W2034813612 cites W2136648677 @default.
• W2034813612 cites W2144278357 @default.
• W2034813612 cites W2148776079 @default.
• W2034813612 cites W2150659072 @default.
• W2034813612 cites W2159024688 @default.
• W2034813612 cites W2162305597 @default.
• W2034813612 cites W2164509468 @default.
• W2034813612 cites W2326523156 @default.
• W2034813612 doi "https://doi.org/10.1096/fj.14-258046" @default.
• W2034813612 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25114177" @default.
• W2034813612 hasPublicationYear "2014" @default.
• W2034813612 type Work @default.
• W2034813612 sameAs 2034813612 @default.
• W2034813612 citedByCount "17" @default.
• W2034813612 countsByYear W20348136122015 @default.
• W2034813612 countsByYear W20348136122016 @default.
• W2034813612 countsByYear W20348136122017 @default.
• W2034813612 countsByYear W20348136122018 @default.
• W2034813612 countsByYear W20348136122019 @default.
• W2034813612 countsByYear W20348136122020 @default.
• W2034813612 countsByYear W20348136122021 @default.
• W2034813612 countsByYear W20348136122022 @default.
• W2034813612 countsByYear W20348136122023 @default.
• W2034813612 crossrefType "journal-article" @default.
• W2034813612 hasAuthorship W2034813612A5004347562 @default.
• W2034813612 hasAuthorship W2034813612A5006651636 @default.
• W2034813612 hasAuthorship W2034813612A5012463050 @default.
• W2034813612 hasAuthorship W2034813612A5018073098 @default.
• W2034813612 hasAuthorship W2034813612A5022501218 @default.
• W2034813612 hasAuthorship W2034813612A5035093874 @default.
• W2034813612 hasAuthorship W2034813612A5046732096 @default.
• W2034813612 hasAuthorship W2034813612A5068462524 @default.
• W2034813612 hasAuthorship W2034813612A5069617479 @default.
• W2034813612 hasAuthorship W2034813612A5076141593 @default.
• W2034813612 hasAuthorship W2034813612A5082227068 @default.
• W2034813612 hasAuthorship W2034813612A5090242706 @default.
• W2034813612 hasAuthorship W2034813612A5090728786 @default.
• W2034813612 hasConcept C111684460 @default.
• W2034813612 hasConcept C159654299 @default.
• W2034813612 hasConcept C171279029 @default.
• W2034813612 hasConcept C175773311 @default.
• W2034813612 hasConcept C185592680 @default.

• next